CASI Pharmaceuticals
CASI
#10191
Rank
S$20.82 M
Marketcap
S$1.01
Share price
5.68%
Change (1 day)
-68.65%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -S$62.15 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are S$26.84 Million. In 2024 the company made an earning of -S$48.23 Million a decrease over its 2023 earnings that were of -S$33.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$62.15 Million28.88%
2024 -S$48.23 Million44.35%
2023 -S$33.41 Million-29.55%
2022 -S$47.42 Million4.43%
2021 -S$45.41 Million-24.56%
2020 -S$60.19 Million4.74%
2019 -S$57.46 Million65.13%
2018 -S$34.8 Million155.07%
2017 -S$13.65 Million13.93%
2016 -S$11.98 Million31.18%
2015 -S$9.13 Million-72.5%
2014 -S$33.19 Million356.62%
2013 -S$7.27 Million-60.55%
2012 -S$18.43 Million218.41%
2011 -S$5.79 Million0.74%
2010 -S$5.75 Million-32.54%
2009 -S$8.52 Million-66.98%
2008 -S$25.79 Million-14.22%
2007 -S$30.06 Million7.04%
2006 -S$28.09 Million27.95%
2005 -S$21.95 Million4.51%
2004 -S$21.01 Million-15.84%
2003 -S$24.96 Million-55.29%
2002 -S$55.82 Million-34.05%
2001 -S$84.63 Million31.73%
2000 -S$64.25 Million31.56%
1999 -S$48.84 Million145.56%
1998 -S$19.89 Million76.4%
1997 -S$11.28 Million36.92%
1996 -S$8.24 Million